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Introduction
The prognosis of high-grade glioma (HGG) is poor despite
advancements in neurosurgery, radio-and chemotherapy.
DC-based immunotherapy has emerged as a promising
and feasible treatment approach due to its high degree of
selectivity and its ability to induce an antigen-specific
immune-memory response. Our research group investi-
gates the efficacy of vaccinating both primary and relapsed
HGG patients with DC vaccines pulsed with autologous
whole tumor lysate. The method of preparing autologous
whole tumor lysate is, however, not standardized yet with
most groups applying multiple freeze-thaw (FT) cycles to
induce necrosis of tumor cells. As irradiation is known to
induce oxidation-associated molecular patterns (OAMPs)
like oxidized or carbonylated proteins, potent enablers of
danger signaling, we hypothesized that irradiation could
increase the immunogenicity of FT-treated necrotic tumor
cells used to pulse DC vaccines in the context of HGG.
Methodology
All experiments were performed in the murine syn-
geneic GL261 orthotopic glioma model. Prophylactic
DC immunotherapy was performed with murine bone
marrow-derived DCs pulsed with total GL261 lysate.
Total GL261 lysate was either prepared by subjecting
GL261 cells to six FT cycles (GL261-FT) or by addition-
ally applying 60 Gy X-irradiation after the six FT cycles
(GL261-FT+IR).
Results
Protein oxidation/carbonylation, an indirect measure of
proteotoxicity-based immunogenicity, was significantly
increased in GL261-FT+IR as compared to GL261-FT.
We observed no differences in the expression levels of
DC maturation markers (CD80, CD86, CD40, MHC-I
and MHC-II) on matured DCs pulsed with either GL261-
FT or GL261-FT+IR lysates. Flowcytometric analysis of
brain-infiltrating immune cells revealed an increased
infiltration of CD3+ T cells and a decreased infiltration
of FoxP3+ Tregs, F4/80+ macrophages and Ly6C+ and
Ly6G+ myeloid-derived suppressor cells in mice receiv-
ing prophylactic DC vaccines pulsed with GL261-FT+IR
as compared to mice treated with DCs pulsed with
GL261-FT. Moreover, vaccination of mice with DCs
loaded with GL261-FT+IR resulted in a significant
improvement of overall survival, compared to mice trea-
ted with DCs pulsed with GL261-FT.
Conclusion
Collectively, these data suggest that irradiation of necro-
tic tumor cells used to pulse DC can further increase
the DC vaccine-induced anti-tumor immunity in the
context of glioma. We are currently evaluating the con-
tribution of the irradiation-induced OAMPs to the
increased immunogenicity of the GL261-FT+IR lysate.
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